Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Aprea Therapeutics Inc.

Aprea Therapeutics Inc. (APRE)

Market is closed
News
  • Displaying 4
Is Aprea Therapeutics, Inc. (APRE) A Good Stock To Buy?

Is Aprea Therapeutics, Inc. (APRE) A Good Stock To Buy?

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...

Keep Reading →

June 13th, 2021 - Hedge Funds News

10 Biggest Stock Gainers and Losers Today

10 Biggest Stock Gainers and Losers Today

U.S. stocks rallied on Monday after President Donald Trump signed a Covid-19 aid bill.

Keep Reading →

December 28th, 2020 - Market Movers News

Is APRE A Good Stock To Buy Now?

Is APRE A Good Stock To Buy Now?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

December 10th, 2020 - Hedge Funds News

Hedge Funds Warming Up To Aprea Therapeutics, Inc. (APRE)

Hedge Funds Warming Up To Aprea Therapeutics, Inc. (APRE)

In this article we will check out the progression of hedge fund sentiment towards Aprea Therapeutics, Inc. (NASDAQ:APRE) and determine whether it is a good investment right now.

Keep Reading →

June 12th, 2020 - Hedge Funds News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)